Pinned
KN671 OS and HRQoL! Check it out:
sciencedirect.com/science/articl…
Jonathan Spicer MD PhD
5,553 posts
Jonathan Spicer MD PhD
@DoctorJSpicer
Medical Director of the McGill Thoracic Oncology Program; Chest surgeon; Neutrophil biologist; Cancer immunologist; Aspiring farmer
- No joke - we had a patient swallow Lysol as a #disinfectant a couple of weeks ago to prevent COVID19 infection. He made it out of the hospital after his gastrectomy... This kind of nonsense is absolutely mind blowing.
- Quel imbécile ce @francoislegault! Comme si c’était la faute du PM de l’Ontario que les médecins québécois cherchent à quitter. Il faut vraiment être abrutit pour penser que les professionnels les plus éduqués de la province seraient prisonniers d’une province qui les maltraite.Nouveau Doug Ford qui invite les médecins québécois à venir en Ontario est un « manque de jugement total et inacceptable » selon @francoislegault #polqc #polcan
- Hard to believe but after 8 long years, the Spicer lab @RIMUHC1 finally has @CIHR_IRSC funding! Thank you to my amazing collaborators @DanielaQuail @loganawalsh @McGillGCI, Dr Morgan Craig @UMontreal. Never possible without the amazing stewardship of @ronirayes from the start!
- T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Hot stuff coming out in @CellCellPress on #neutrophils and #immunotherapy!
- L’homme sur lequel j’ai calqué ma carrière et qui a servi de mentor à tant de chirurgiens talentueux sur une période de 50 ans l’explique mieux que personne. Dr David Mulder parle d’une époque où le Québec fut un pôle recruteur et il en est l’exemple classique. Un jeune homme
- Why is CM816 so important? After @FordePatrick beautiful presentation of these revolutionary data, let’s dig into why this unique trial should shake up our vision for oncology research…
- Just like CM816, for those saying there is no OS effect, I ask you which curve do you prefer for your patients? Let’s just give it a bit of time, eh? @NEJM @ASCO @IASLC @AATSHQ @thoracic @ThoracicsCanada #ASCO23 nejm.org/doi/full/10.10…
- Exciting list in the OR today! Case #1: post-NeoADAURA stage IIA Case #2: post-chemo+Nivo stage IIA Case #3: post-NeoCOAST2 stage IIIA Thrilled to be operating with our fellow @bulgalucho! @MThoracics @cusm_muhc @CodeVie_Life @CedarsCancer #LCSM
- A beautiful lung cancer paper by @JonesDavid2013 and @MSK_Thoracic team! A key finding is that only 4% of metastatic lesions harbour actionable mutations not previously identified in the primary - an important argument for molecular testing in early stage!
- To any health care institution or headhunter seeking world-class physicians and surgeons, the Quebec legistlature has passed a new special law severly impacting the civil and professional liberties of medical practitioners in our province, where average remuneration was already
- It seems we are in a bit of a data quagmire. I often get asked how to choose between neoadjuvant versus perioperative immunotherapy and right now there aren’t many great answers, but for what it’s worth, here’s my general perspective… #ASCO25
